California Resources vs Crescent Energy
CRC and CRGY side by side, both in crude petroleum and natural gas. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRC and CRGY compare
California Resources and Crescent Energy are about the same size, with market caps of $4.3B and $4.0B.
Crescent Energy grew revenue faster over the last twelve months (33.5% versus −22.5% for California Resources).
Crescent Energy keeps more of each dollar of sales as profit, with a net margin of 1.3% compared with −3.8% at California Resources.
Both pay dividends: California Resources yields 3.4% and Crescent Energy 4.0%.
California Resources scores higher on the StockData Score (10 against 8 for Crescent Energy), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRC | CRGY |
|---|---|---|
| Size and price | ||
| Market cap | $4.3B | $4.0B |
| Share price | $48.31 | $12.12 |
| Change, 1 year | 1.3% | 32.9% |
| Change, 5 years | 19.2% | – |
| Beta (5Y) | 0.71 | 0.90 |
| Employees | 2,500 | 1,066 |
| StockData Score | ||
| Total score | 10 (better) | 8 |
| Valuation score | 2 | 3 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 3 (better) | 1 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/S | 1.3× | 0.8× (better) |
| P/B | 1.3× | – |
| EV/EBITDA | 12.0× | 3.2× (better) |
| P/FCF | 11.1× | – |
| FCF yield | 9.0% | – |
| Fair value | $57.85 | $33.95 |
| Margin of safety | 16.5% | 64.3% (better) |
| Growth | ||
| Revenue growth (TTM) | −22.5% | 33.5% (better) |
| Revenue growth, 5Y average | – | 36.5% |
| Net income growth (TTM) | −118% | 164% (better) |
| EPS growth (TTM) | −119% | – |
| Profitability | ||
| Operating margin | −1.7% | 27.8% (better) |
| Net margin | −3.8% | 1.3% (better) |
| FCF margin | 12.1% | – |
| Return on equity | −3.6% | – |
| Return on invested capital | −0.97% | – |
| Financial health | ||
| Debt / equity | 0.38 | – |
| Net debt / EBITDA | 2.66 | 1.74 (better) |
| Interest coverage | – | 3.5× |
| Current ratio | 0.66 | 0.67 (better) |
| Altman Z-score | 1.38 (better) | 1.10 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.4% | 4.0% (better) |
| Payout ratio | – | 240% |
| Years of dividend growth | 4 | – |
| Buyback yield | 1.6% (better) | −0.01% |
| Shareholder yield | 4.9% (better) | 4.0% |
| Ownership | ||
| Held by institutions | 103% | 91.3% |
| Held by insiders | 13.7% | 34.8% |
| Insider net buying, 12 months | −$223M (better) | −$402M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 5.8% | 16.9% |
Go deeper
- CRC stock overview
- CRC income statement
- CRC valuation and score
- CRGY stock overview
- CRGY income statement
- CRGY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.